Linx Electronic Specialty Gases & Systems (ESGS) 2024
The Electronic Specialty Gases & Systems 2024 Conference provides a forum of engagement and learning around the market, technology trends, and market drivers for electronic gases and systems.
Type of Event
Other
Our Participation
Sponsor
22 Oct 2024 - 24 Oct 2024
Intro
The ESGS 2024 includes sections focusing on developments in the bulk, rare and specialty gas markets that are critical to the continued growth of the electronics industry.
The conference is designed for executives, buyers, product managers, and strategic planners from the electronic gases value chain including end-users, producers, and equipment suppliers. The conference features knowledgeable experts in the industry, who understand the key developments and challenges unique to this market.
SEMICONDUCTOR SOLUTIONS information kit
Download your kit to unlock exclusive content on our sustainability transformation & how our Materials Intelligence™ enables innovation for more sustainable solutions across the semiconductor value chain.
If you do not see the form, please click here.
Keynote Speech
-
Bing Han
General Manager, Dielectrics, Thin Films
Advancing Technology Roadmaps through Collaborative Material Development
22 Oct 2024 - FROM 13:20 TO 14:00 UTC-07:00
Future Ways of Working and Generative AI Disruption
AI will not replace innovators, but innovators who use AI will replace innovators who don’t.
Related News
View All News-
Press Releases
Global Hackathon by Merck KGaA, Darmstadt, Germany, and Boltz Sets New Benchmark ...
Our global hackathon on protein folding has set a new benchmark for open-source AI-driven innovation in drug development.
2025/10/27
-
Press Releases
Launch of EdiMembre to Transform Alternative Protein Industry
Together with mantro GmbH we have established EdiMembre, Inc., Massachusetts, U.S.A., a Deep Tech spin-out in the alternative protein industry.
2025/08/18
-
Press Releases
European Commission Grants Approval of Ogsiveo
The European Commission granted approval for Ogsiveo for the treatment of adults with desmoid tumors.
2025/08/18